102 related articles for article (PubMed ID: 2754807)
1. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; measurement with new synthetic substrate method].
Ujiie M; Kuroiwa K; Nagasawa T; Sato Y; Kitahara N
Rinsho Byori; 1989 Apr; Spec No 81():208-13. PubMed ID: 2754807
[No Abstract] [Full Text] [Related]
2. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; new synthetic chromogenic substrate assays for hemostatic parameters].
Hiura H; Nishiyama T; Kimura M; Matoba K; Hayashi O; Sasaki M; Ishijima C; Irie Y; Yasuda N
Rinsho Byori; 1989 Apr; Spec No 81():214-9. PubMed ID: 2754808
[No Abstract] [Full Text] [Related]
3. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
[No Abstract] [Full Text] [Related]
4. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
6. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
7. Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
Aiach M; Léon M; Michaud A; Capron L
Semin Thromb Hemost; 1983 Jul; 9(3):206-16. PubMed ID: 6351255
[No Abstract] [Full Text] [Related]
8. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
[No Abstract] [Full Text] [Related]
9. Disseminated intravascular coagulation: antithrombin, plasminogen, and coagulation abnormalities in 41 dogs.
Feldman BF; Madewell BR; O'Neill S
J Am Vet Med Assoc; 1981 Jul; 179(2):151-4. PubMed ID: 7263467
[TBL] [Abstract][Full Text] [Related]
10. Univariate tolerance regions for fibrinogen, antithrombin III, protein C, protein S, plasminogen and alpha 2-antiplasmin in children using the new Automated Coagulation Laboratory (ACL) method.
Nowak-Göttl U; Funk M; Mosch G; Wegerich B; Kornhuber B; Breddin HK
Klin Padiatr; 1994; 206(6):437-9. PubMed ID: 7529848
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic efficacy of six plasma proteins in evaluating consumptive coagulopathies. Use of receiver operating characteristic curves to compare antithrombin III, plasminogen, alpha 2-plasmin inhibitor, fibronectin, prothrombin, and protein C.
Cembrowski GS; Griffin JH; Mosher DF
Arch Intern Med; 1986 Oct; 146(10):1997-2002. PubMed ID: 3767544
[TBL] [Abstract][Full Text] [Related]
12. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
Collen D
Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
[No Abstract] [Full Text] [Related]
13. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptide substrate assays in coagulation and fibrinolysis and their application on automates.
Friberger P
Semin Thromb Hemost; 1983 Oct; 9(4):281-300. PubMed ID: 6362011
[No Abstract] [Full Text] [Related]
15. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
Itoh N
Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
[No Abstract] [Full Text] [Related]
16. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
Collatos C; Barton MH; Prasse KW; Moore JN
J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
[TBL] [Abstract][Full Text] [Related]
17. Automation in coagulation testing. Clinical applications.
Messmore HL
Semin Thromb Hemost; 1983 Oct; 9(4):341-5. PubMed ID: 6606852
[No Abstract] [Full Text] [Related]
18. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
Lanevschi A; Kramer JW; Greene SA; Meyers KM
Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
Rodzynek JJ; Urbain D; Leautaud P; Wettendorff P; Delcourt A
Gut; 1984 Oct; 25(10):1050-6. PubMed ID: 6479679
[TBL] [Abstract][Full Text] [Related]
20. Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.
Hayakawa M; Maki M
Gynecol Obstet Invest; 1988; 26(3):181-90. PubMed ID: 3240888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
